Diabetes Mellitus and Heart Failure: Epidemiology, Pathophysiologic Mechanisms, and the Role of SGLT2 Inhibitors

11Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

Abstract

Diabetes mellitus (DM) and heart failure (HF) are frequently encountered afflictions that are linked by a common pathophysiologic background. According to landmark studies, those conditions frequently coexist, and this interaction represents a poor prognostic indicator. Based on mechanistic studies, HF can be propagated by multiple pathophysiologic pathways, such as inflammation, oxidative stress, endothelial dysfunction, fibrosis, cardiac autonomic neuropathy, and alterations in substrate utilization. In this regard, DM may augment myocardial inflammation, fibrosis, autonomic dysfunction, and lipotoxicity. As the interaction between DM and HF appears critical, the new cornerstone in DM and HF treatment, sodium-glucose cotransporter-2 inhibitors (SGLT2i), may be able to revert the pathophysiology of those conditions and lead to beneficial HF outcomes. In this review, we aim to highlight the deleterious pathophysiologic interaction between DM and HF, as well as demonstrate the beneficial role of SGLT2i in this field.

References Powered by Scopus

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9<sup>th</sup> edition

7118Citations
N/AReaders
Get full text

Role of diabetes in congestive heart failure: The Framingham study

1773Citations
N/AReaders
Get full text

Myocardial fatty acid metabolism in health and disease

1730Citations
N/AReaders
Get full text

Cited by Powered by Scopus

SGLT-2 Inhibitors and the Inflammasome: What’s Next in the 21st Century?

19Citations
N/AReaders
Get full text

Slowing the Progression of Diabetic Kidney Disease

13Citations
N/AReaders
Get full text

Evidence of a bi-directional relationship between heart failure and diabetes: a strategy for the detection of glucose abnormalities and diabetes prevention in patients with heart failure

3Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Theofilis, P., Oikonomou, E., Tsioufis, K., & Tousoulis, D. (2023, February 1). Diabetes Mellitus and Heart Failure: Epidemiology, Pathophysiologic Mechanisms, and the Role of SGLT2 Inhibitors. Life. MDPI. https://doi.org/10.3390/life13020497

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

63%

Professor / Associate Prof. 1

13%

Lecturer / Post doc 1

13%

Researcher 1

13%

Readers' Discipline

Tooltip

Medicine and Dentistry 10

63%

Pharmacology, Toxicology and Pharmaceut... 3

19%

Nursing and Health Professions 2

13%

Biochemistry, Genetics and Molecular Bi... 1

6%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free